THE RELATIONSHIP BETWEEN BODY MASS INDEX AND RISK OF ACUTE CORONARY SYNDROME IN PATIENTS WITH TYPE 2 DIABETES
Main Article Content
Keywords
Body mass index, Type-2 diabetes, Acute coronary syndrome, obesity, etc.
Abstract
Introduction: Body mass index, the risk of cardiovascular events, and all-cause mortality are related in diabetics is a debatable matter. Diabetes patients are more likely to experience cardiovascular complications. It is commonly known that obesity raises the risk of cardiovascular disease (CVD) in the general population. Little is known about the relationship between BMI and major adverse cardiovascular events, despite the fact that these are important health outcomes for individuals with diabetes. The connection between a person's BMI and mortality in those with diabetes has been the subject of continuous discussion. "Obesity paradox" in diabetics is often documented, suggesting that the mortality rates of individuals with diabetes who have elevated BMIs are lower than those of individuals whose BMIs are thought to represent normal weight.
Aim of the Study: The purpose of the present review is to understand the relationship between body mass index (BMI) and cardiovascular complications like acute coronary syndrome in patients with Type -2 Diabetes.
Methodology: The review is a comprehensive research of PUBMED from 1997 to 2023.
Conclusion: Despite the debate, it is suggested that patients who do not receive insulin therapy and have type 2 diabetes mellitus also maintain the obesity paradox. The lowest and highest mortality rates were found in class I obese patients and the normal weight population, respectively, when examining the relationship between BMI and all-cause mortality in patients with type 2 diabetes mellitus and ACS. The benefit of obesity for survival was eliminated for patients on insulin therapy.
References
2. Tobias D K, Pan A, Jackson C L, O'Reilly E J, Ding E L, Willett W C, & Hu F B (2014). Body-mass index and mortality among adults with incident type 2 diabetes. New England Journal of Medicine, 370(3), 233-244.
3. Gruberg L, Weissman N J, Waksman R, Fuchs S, Deible R, Pinnow E E, & Lindsay J (2002). The impact of obesity on the short-term andlong-term outcomes after percutaneous coronary intervention: the obesity paradox?. Journal of the American College of Cardiology, 39(4), 578-584.
4. Smith Jr S C, Benjamin E J, Bonow R O, Braun L T, Creager M A, Franklin B A, & Taubert K A (2011). AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation, 124(22), 2458-2473.
5. Colombo M G, Meisinger C, Amann U, Heier M, von Scheidt W, Kuch B, & Kirchberger I (2015). Association of obesity and long-term mortality in patients with acute myocardial infarction with and without diabetes mellitus: results from the MONICA/KORA myocardial infarction registry. Cardiovascular diabetology, 14, 1-10.
6. Paneni F, & Lüscher T F (2017). Cardiovascular protection in the treatment of type 2 diabetes: a review of clinical trial results across drug classes. The American journal of cardiology, 120(1), S17-S27.
7. Bays H E (2011). Adiposopathy: is “sick fat” a cardiovascular disease?. Journal of the American College of Cardiology, 57(25), 2461-2473.
8. Tishkoff S A, & Kidd K K (2004). Implications of biogeography of human populations for'race'and medicine. Nature genetics, 36(Suppl 11), S21-S27.
9. Lanting L C, Joung I M, Mackenbach J P, Lamberts S W, & Bootsma A H (2005). Ethnic differences in mortality, end-stage complications, and quality of care among diabetic patients: a review. Diabetes care, 28(9), 2280-2288.
10. Lee D H, Ha K H, Kim H C, & Kim D J (2018). Association of body mass index with risk of major adverse cardiovascular events and mortality in people with diabetes. Journal of obesity & metabolic syndrome, 27(1), 61.
11. Wan E Y F, Fung C S C, Fong D Y T, Chan A K C, & Lam C L K (2016). A curvilinear association of body mass index with cardiovascular diseases in Chinese patients with type 2 diabetes mellitus–A population-based retrospective cohort study. Journal of Diabetes and its Complications, 30(7), 1261-1268.
12. Costanzo P, Cleland J G, Pellicori P, Clark A L, Hepburn D, Kilpatrick E S, & Atkin S L (2015). The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study. Annals of internal medicine, 162(9), 610-618.
13. Eeg-Olofsson K, Cederholm J, Nilsson P M, Zethelius B, Nunez L, Gudbjörnsdóttir S, & Eliasson B (2009). Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients. Diabetologia, 52, 65-73.
14. Lavie C J, McAuley P A, Church T S, Milani R V, & Blair S N (2014). Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. Journal of the American college of cardiology, 63(14), 1345-1354.
15. Andreadi A, Muscoli S, Tajmir R, Meloni M, Muscoli C, Ilari S, & Lauro D (2023). Recent pharmacological options in type 2 diabetes and synergic mechanism in cardiovascular disease. International Journal of Molecular Sciences, 24(2), 1646.
16. American Diabetes Association. (2018). 8. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes—2018. Diabetes care, 41(Supplement_1), S73-S85.
17. Colombo M G, Meisinger C, Amann U, Heier M, von Scheidt W, Kuch B, & Kirchberger I (2015). Association of obesity and long-term mortality in patients with acute myocardial infarction with and without diabetes mellitus: results from the MONICA/KORA myocardial infarction registry. Cardiovascular diabetology, 14, 1-10.
18. Nolan C J, Ruderman N B, Kahn S E, Pedersen O, & Prentki M (2015). Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes. Diabetes, 64(3), 673-686.
19. Yki-Järvinen H, Ryysy L, Kauppila M, Kujansuu E, Lahti J, Marjanen T, & Taskinen M R (1997). Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus. The Journal of Clinical Endocrinology & Metabolism, 82(12), 4037-4043.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Mohammed Mughabbish Thafrani
Jazan health cluster- western sector - Jazan - Saudi Arabia
Mustafa Hussain Sabie
Jazan health cluster- western sector - Jazan - Saudi Arabia
Mohammad Ahmed Motwwam
Jazan Health Sector - Middle sector - Jazan - Saudi Arabia
Abdullatif Alhassan Fathi
Aseer health cluster - Muhail sector - Aseer - Saudi Arabia
Abdullah Ali Shabani
Jazan health cluster- western sector - Jazan - Saudi Arabia
Alhassan Hamood Derban
Jazan health cluster- western sector - Jazan - Saudi Arabia